S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
Log in

LON:BPCR - Biopharma Credit Share Price, Forecast & News

GBX 0.99
-0.01 (-1.00 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
0.99
Now: GBX 0.99
1
50-Day Range
1
MA: GBX 1.01
1.02
52-Week Range
0.94
Now: GBX 0.99
1.07
Volume2.05 million shs
Average Volume64,237 shs
Market Capitalization£13.57 million
P/E Ratio10.51
Dividend Yield6.90%
BetaN/A
BioPharma Credit PLC, an investment trust, invests in interest-bearing debt assets secured by royalties or other cash flows derived from the royalties and sales of life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

Industry, Sector and Symbol

Industry Asset Management
Sub-IndustryN/A
SectorFinancial Services
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£141.97 million
Cash FlowGBX 44.11 per share
Book ValueGBX 102.60 per share

Profitability

Miscellaneous

EmployeesN/A
Outstanding Shares1,373,929,984
Market Cap£13.57 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BPCR News and Ratings via Email

Sign-up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter.


Biopharma Credit (LON:BPCR) Frequently Asked Questions

What is Biopharma Credit's stock symbol?

Biopharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR."

How often does Biopharma Credit pay dividends? What is the dividend yield for Biopharma Credit?

Biopharma Credit announced a dividend on Thursday, February 20th. Shareholders of record on Thursday, February 27th will be given a dividend of GBX 0.03 per share on Friday, March 27th. This represents a yield of 2.97%. The ex-dividend date of this dividend is Thursday, February 27th. This is an increase from Biopharma Credit's previous dividend of $0.02. The official announcement can be accessed at this link. View Biopharma Credit's Dividend History.

Has Biopharma Credit been receiving favorable news coverage?

News headlines about BPCR stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Biopharma Credit earned a news impact score of 1.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Biopharma Credit.

Who are some of Biopharma Credit's key competitors?

What other stocks do shareholders of Biopharma Credit own?

Who are Biopharma Credit's key executives?

Biopharma Credit's management team includes the folowing people:
  • Mr. Pedro Gonzalez de Cosio, Investment Mang.
  • Mr. Pablo G. Legorreta, Investment Mang.
  • Mr. Martin G. Friedman, Investment Mang. (Age 54)

How do I buy shares of Biopharma Credit?

Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Biopharma Credit's stock price today?

One share of BPCR stock can currently be purchased for approximately GBX 0.99.

How big of a company is Biopharma Credit?

Biopharma Credit has a market capitalization of £13.57 million and generates £141.97 million in revenue each year. View Additional Information About Biopharma Credit.

What is Biopharma Credit's official website?

The official website for Biopharma Credit is http://www.bpcruk.com/.


MarketBeat Community Rating for Biopharma Credit (LON BPCR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  84 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  176
MarketBeat's community ratings are surveys of what our community members think about Biopharma Credit and other stocks. Vote "Outperform" if you believe BPCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BPCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel